Kuwait Adult Diabetes Epidemiological Multidisciplinary Program
Official title: Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program
Run by Dasman Diabetes Institute · NCT06115876 · Data updated 2026-11-12
This study looks at people in Kuwait to see how obesity and genetics affect the risk of developing prediabetes and diabetes, hoping to find better ways to prevent these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 75 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Dasman Diabetes Institute Academic / other |
| Locations | 1 site (Kuwait City) |
| Status | Recruiting |
| Started | May 23, 2022 |
| Main results expected | May 23, 2027 |
| Study ends | May 23, 2027 |
| Registry record updated | November 3, 2023 |
| Trial ID | NCT06115876 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals who participated in the original KDEP study, as well as those diagnosed with prediabetes or Type 2 diabetes.
✕Probably not a fit
Patients who are unwilling to sign the consent form or are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program aims to follow up on participants from the Kuwait Diabetes Epidemiology Program to identify risk factors for prediabetes and diabetes in the Kuwaiti population. It focuses on understanding the impact of obesity and genetic factors on the onset of diabetes and related metabolic disorders. By collecting longitudinal data, the study seeks to enhance the understanding of diabetes progression and inform prevention strategies. The research will utilize a multidisciplinary approach, incorporating genetics, biochemistry, and epidemiology.
Why it matters
Potential benefit: If successful, this program could lead to improved prevention and management strategies for diabetes and related conditions in the Kuwaiti population.
How similar studies have gone: Other studies in similar populations have shown success in identifying risk factors for diabetes, but this program aims to provide a more comprehensive longitudinal perspective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: People who participated in the original KDEP study. People with prediabetes. Type 2 Diabetes patients. Exclusion Criteria: People are unwilling to sign the consent form. Pregnant women.
Where it's running
-
Dasman Diabetes Institute
Kuwait City, Kuwait Recruiting
Study contacts
- Study coordinator: Mohamed Abu-farha, PhD
- Email: mohamed.abufarha@dasmaninstitute.org
- Phone: +96560660804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD
This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
-
Smart probiotic and nutraceutical approach for cardiometabolic health in older adults
This trial tests whether a probiotic-containing nutraceutical strategy can improve metabolic health and blood pressure in adults over 65 with prediabetes or cardiovascular disease.
-
Family-based diabetes prevention for parents and kids
A family-focused program tests whether a 12-week lifestyle plan can help parents at risk for diabetes lose weight and improve healthy habits for themselves and their children aged 12–17.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.